Ensayo clínico

Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer

NCT: NCT07781852 · NOT_YET_RECRUITING

ID NCTNCT07781852

EstadoNOT_YET_RECRUITING

Fecha de inicio2026-09-01

Finalización2027-09-01

SponsorLumina Pharmaceuticals Inc (INDUSTRY)

First posted2026-08-24

Last updated2026-08-28

Resumen breve

The objective of this study is to assess two novel positron emission tomography (PET) radiotracers, \[64Cu\]CM500 and \[68Ga\]CM500, for Positron Emission Tomography-Magnetic Resonance Imaging (PET-MR) and Positron Emission Tomography / Computed Tomography (PET-CT) imaging of solid tumors. These tracers have the potential to detect solid tumors throughout the body and may enable doctors to identify smaller tumors than conventional imaging techniques.

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.